Skip to main content
Bryan Burt, MD, Thoracic Surgery, Los Angeles, CA

Bryan Michael Burt MD FACS (He/Him)

Adult General Thoracic Surgery, Minimally Invasive Thoracic Surgery, Thoracic Surgical Oncology


Professor of Surgery and Chief, Division of Thoracic Surgery, UCLA Health

Join to View Full Profile
  • 200 Medical Plaza, Suite B265Los Angeles, CA 90095

  • Phone+1 310-267-9099

  • Fax+1 310-794-9737

Dr. Burt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Children's Hospital
    Mass General Brigham/Brigham and Women's Hospital/Children's HospitalFellowship, Thoracic Surgery - Independent, 2010 - 2012
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Surgery, 2003 - 2010
  • Weill Cornell Medicine
    Weill Cornell MedicineClass of 2003

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2012 - 2026
  • TX State Medical License
    TX State Medical License 2014 - 2024
  • MA State Medical License
    MA State Medical License 2011 - 2016
  • Surgery
    American Board of Surgery Surgery
  • Thoracic and Cardiac Surgery
    American Board of Thoracic Surgery Thoracic and Cardiac Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Publications & Presentations

PubMed

Journal Articles

  • Povidone-Iodine Results in Rapid Killing of Thymic Epithelial Tumour Cells Through Cellular Fixation  
    David J Sugarbaker, Eric M Lo, Shawn S Groth, Bryan M Burt, Interactive CardioVascular and Thoracic Surgery

Other

Press Mentions

  • The Immunopeptidome of Malignant Pleural Mesothelioma
    The Immunopeptidome of Malignant Pleural MesotheliomaMay 8th, 2023
  • Preoperative Immunotherapy for Mesothelioma Shows Favorable Outcomes
    Preoperative Immunotherapy for Mesothelioma Shows Favorable OutcomesDecember 13th, 2022
  • Tiny 'Drug Factory' Implants Can Eradicate Tumors in Mice in Just Days
    Tiny 'Drug Factory' Implants Can Eradicate Tumors in Mice in Just DaysSeptember 12th, 2022
  • Join now to see all

Grant Support

  • Validation and Translation of MasSpec Pen Technology for Intraoperative Evaluation of Non-small Cell Lung CancerBAYLOR COLLEGE OF MEDICINE2023–2028
  • Proteomic determinants of response to checkpoint blockade in malignant pleural mesotheliomaUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Proteomic determinants of response to checkpoint blockade in malignant pleural mesotheliomaUNIVERSITY OF CALIFORNIA LOS ANGELES2021–2025
  • Natural Killer Dendritic Cells In CancerNational Cancer Institute2006–2007

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: